Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2018720895
Up to date per 10.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2018720895
Title / Product Name
NIRAPARIB, ABIRATERONACETAT UND PREDNISON ZUR BEHANDLUNG VON PROSTATAKREBS
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2018720895
EP Publication Number
3609497
E-Number
1523741
Language
EN
PCT Number
US18026661
Publication Date
19.02.2020 A
12.10.2022 B1
Registration Date
12.10.2022
AT Publication Date
15.11.2022
Application Date
09.04.2018
Registration Number
-
Priorities
13.04.2017
US
201762485164 P
IPC
A61K 31/454 20060101AFI20181019BHEP
Maximum Duration of Protection
09.04.2038
Owner
Janssen Pharmaceutica NV
Turnhoutseweg 30
2340 Beerse
BE
Representative
Representative
Haffner und Keschmann Patentanwälte GmbH
Schottengasse 3a
1010 Wien
AT
Inventor
YU, Margaret K.
10990 Wilshire Blvd., Suite 300
Los Angeles, California 90024
US
SNYDER, Linda Anne
1400 McKean Road
Spring House, Pennsylvania 19477
US
Information about Fees
Click here to load the fees
see.ip - Details for NIRAPARIB, ABIRATERONACETAT UND PREDNISON ZUR BEHANDLUNG VON PROSTATAKREBS